Publications

7 June

IP in a Post-pandemic World

23 May

Glargine Insulin: Prices People Pay

26 April

Antimicrobial Resistance: A Multifaceted Approach

24 April

Annual Report 2022

6 April

National diabetes programme: Tanzania’s Transition

5 April

Promoting Health Rights and Access to Medicines in Europe

6 March

Factsheet: The EU Medical Devices Regulation and the AI Act

24 January

Diagnostics to Address Antimicrobial Resistance

25 November

Snakebite Prevention: Safiya’s 8 Secrets

21 November

Licensing and Access to Health Technologies

19 October

The TRIPS Agreement Laid Bare

3 October

Missing Clinical Trial Data in Europe

26 September

Clinical Trial Regulation in Europe

18 July

Intergovernmental Negotiating Body Second Meeting – Statement

15 July

Religion and SRH: Role of faith leaders in Zambia & Burundi

22 June

Snakebite: Case Studies from Kajiado County, Kenya

17 June

HAI statement on the outcome of TRIPS negotiations at WTO MC12

15 June

HAI Statement to Intergovernmental Negotiating Body

25 May

Statement to WHA75 – Health Emergencies

16 May

Access to Insulin – What you need to know at WHA75

16 May

Diabetes Coverage Targets WHA75

15 May

Clinical Trial Integrity and COVID-19

2 May

Response to European Consultation on Compulsory Licensing

13 April

Annual Report 2021

15 February

Interpreting the EU Artificial Intelligence Act for the Health Sector

2 February

Pooled Procurement of Insulin & Associated Supplies

14 December

Report – Community Engagement Meeting on Snakebite Envenoming

3 December

Procurement of Insulins & Associated Supplies

24 November

Medicine Pricing and Access in Europe

27 October

Regulatory Profile for Glucose Self-monitoring Tools